Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Longer Term Follow up of the Â Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT)

Brian GM Durie, MD, Antje Hoering, PhD, Rachael Sexton, PhD, Muneer H. Abidi, MD, Joshua Epstein, DSc, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Stephen P. Kahanic, MD, Mohan C. Thakuri, MD, Frederic J. Reu, MD, Christopher M. Reynolds, MD, Robert Z. Orlowski, MD PhD, Bart Barlogie, MD PhD

Blood (2018) 132 (Supplement 1): 1992.

https://doi.org/10.1182/blood-2018-99-117003

Published: 2018

Journal Articles

Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777

Brian Durie, MD, Antje Hoering, PhD, S. Vincent Rajkumar, MD, Muneer H. Abidi, MD, Joshua Epstein, DSc, Stephen P. Kahanic, MD, Mohan C. Thakuri, MD, Frederic J Reu, Christopher M. Reynolds, MD, Rachael Sexton, MS, Robert Z. Orlowski, PhD, MD, Bart Barlogie, MD PhD, Angela Dispenzieri, MD

Blood (2015) 126 (23): 25.

https://doi.org/10.1182/blood.V126.23.25.25

Published: 2015

Journal Articles

Possible Role of Engraftment Syndrome in Myelodysplastic Syndrome after Autologous Transplants.

Yi Kong Keung, MD, Michael W Beaty, Mark Pettenati, Denise Levitan, MD, Istvan Molnar, MD, Mohan C. Thakuri, MD, Julia Cruz, MD, David Duane Hurd, MD

Blood (2008) 112 (11): 2156.

https://doi.org/10.1182/blood.V112.11.2156.2156

Published: 2008

Journal Articles

Limited Phase I Trial of Sequential High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia.

Bayard L. Powell, MD, James Lovato, PhD, Claire Kimbrough, Susan Lyerly, PA-C, Sonya Galloway-Daniels, NP, Cathy Motley, RN, Robin Harrelson, RN, Yi Kong Keung, MD, Mohan C. Thakuri, MD, Istvan Molnar, MD, Denise Levitan, MD, David Duane Hurd, MD

Blood (2006) 108 (11): 4565.

https://doi.org/10.1182/blood.V108.11.4565.4565

Published: 2006

Journal Articles

Copper Deficiency Anemia Is Not Uncommon in a Hematology Practice.

Jason D. Huff, MD, Yi-Kong Keung, MD, Mohan C. Thakuri, MD, Michael W. Beaty, MD, John Owen, MD, Istvan Molnar, MD

Blood (2005) 106 (11): 1681.

https://doi.org/10.1182/blood.V106.11.1681.1681

Published: 2005

NARROW

Longer Term Follow up of the Â Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT)

Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777

Possible Role of Engraftment Syndrome in Myelodysplastic Syndrome after Autologous Transplants.

Limited Phase I Trial of Sequential High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia.

Copper Deficiency Anemia Is Not Uncommon in a Hematology Practice.

Email alerts

ASH Publications

American Society of Hematology

Longer Term Follow up of the Â Randomized Phase III Trial SWOG S0777: Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT)

Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777

Possible Role of Engraftment Syndrome in Myelodysplastic Syndrome after Autologous Transplants.

Limited Phase I Trial of Sequential High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia.

Copper Deficiency Anemia Is Not Uncommon in a Hematology Practice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only